000			02109 a2200577 4500
005			20250516130014.0
264		0	_c20130612
008			201306s 0 0 eng d
022			_a1533-712X
024	7		_a10.1097/JCP.0b013e31827d8a23 _2doi
040			_aNLM _beng _cNLM
100	1		_aDurell, Todd M
245	0	0	_aAtomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. _h[electronic resource]
260			_bJournal of clinical psychopharmacology _cFeb 2013
300			_a45-54 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdrenergic Uptake Inhibitors _xadverse effects
650	0	4	_aAdult
650	0	4	_aAnalysis of Variance
650	0	4	_aAtomoxetine Hydrochloride
650	0	4	_aAttention _xdrug effects
650	0	4	_aAttention Deficit Disorder with Hyperactivity _xdiagnosis
650	0	4	_aDouble-Blind Method
650	0	4	_aExecutive Function _xdrug effects
650	0	4	_aHumans
650	0	4	_aLeast-Squares Analysis
650	0	4	_aPredictive Value of Tests
650	0	4	_aPropylamines _xadverse effects
650	0	4	_aProspective Studies
650	0	4	_aPsychiatric Status Rating Scales
650	0	4	_aPuerto Rico
650	0	4	_aQuality of Life
650	0	4	_aRecovery of Function
650	0	4	_aSeverity of Illness Index
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
650	0	4	_aYoung Adult
700	1		_aAdler, Lenard A
700	1		_aWilliams, Dave W
700	1		_aDeldar, Ahmed
700	1		_aMcGough, James J
700	1		_aGlaser, Paul E
700	1		_aRubin, Richard L
700	1		_aPigott, Teresa A
700	1		_aSarkis, Elias H
700	1		_aFox, Bethany K
773	0		_tJournal of clinical psychopharmacology _gvol. 33 _gno. 1 _gp. 45-54
856	4	0	_uhttps://doi.org/10.1097/JCP.0b013e31827d8a23 _zAvailable from publisher's website
999			_c22381664 _d22381664